Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's disease

被引：0
|
作者：
Whitehead, A. [1 ]
Perdomo, C. [1 ]
Pratt, R. D. [1 ]
机构：
[1] Univ Reading, Med & Pharmaceut Stat Res Unit, Earley Gate, Reading RG6 6FN, Berks, England
来源：
EVIDENCE-BASED MENTAL HEALTH | 2005年 / 8卷 / 01期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1136/ebmh.8.1.15
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [31] Affective theory of mind in people with mild and moderate Alzheimer's disease
    de Lucena, Aline Tavares
    Dos Santos, Tatiana Teresa Belfort Almeida
    Santos, Paulo Fernando Alves
    Dourado, Marcia Cristina Nascimento
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 38 (12)
  • [32] Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer's Disease
    Wilkinson, David
    Schindler, Rachel
    Schwam, Elias
    Waldemar, Gunhild
    Jones, Roy W.
    Gauthier, Serge
    Lopez, Oscar L.
    Cummings, Jeffrey
    Xu, Yikang
    Feldman, Howard H.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (03) : 244 - 251
  • [33] Cognitive and affective Theory of Mind in mild to moderate Alzheimer's disease
    Laisney, Mickael
    Bon, Laetitia
    Guiziou, Catherine
    Daluzeau, Nathalie
    Eustache, Francis
    Desgranges, Beatrice
    JOURNAL OF NEUROPSYCHOLOGY, 2013, 7 (01) : 107 - 120
  • [34] Cognitive stimulation therapy for Alzheimer's disease: the effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil
    Matsuda, Osamu
    INTERNATIONAL PSYCHOGERIATRICS, 2007, 19 (02) : 241 - 252
  • [35] Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease
    Jia, Jianping
    Wei, Cuibai
    Chen, Wei
    Jia, Longfei
    Zhou, Aihong
    Wang, Fen
    Tang, Yi
    Xu, Luoyi
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (01) : 199 - 211
  • [36] Donepezil benefits patients with either mild or moderate Alzheimer's disease over one year
    Waldemar, G
    Winblad, B
    Engedal, K
    Soininen, HS
    Verhey, FRJ
    Wimo, A
    Wetterholm, AL
    Zhang, R
    Haglund, AÅ
    Subbiah, P
    NEUROLOGY, 2000, 54 (07) : A470 - A470
  • [37] COST-EFFECTIVENESS ANALYSIS OF DONEPEZIL AND RIVASTIGMINE FOR MILD TO MODERATE ALZHEIMER'S DISEASE IN TAIWAN
    Chen, T. S.
    Lang, H. C.
    VALUE IN HEALTH, 2013, 16 (03) : A104 - A104
  • [38] Donepezil versus vitamin E in Alzheimer's disease - Part 2: Mild versus moderate-severe Alzheimer's disease
    Onofrj, M
    Thomas, A
    Luciano, AL
    Iacono, D
    Di Rollo, A
    D'Andreamatteo, G
    Di Iorio, A
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (04) : 207 - 215
  • [39] Galantamine improves non-cognitive symptoms as compared to nootropics in outpatients with mild to moderate Alzheimer's disease
    Ibach, B.
    Kuehn, F.
    Gerwe, M.
    Diekamp, B.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 224 - 224
  • [40] Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer’s disease
    Mehmet Yuruyen
    Fundan Engin Akcan
    Gizem Cetiner Batun
    Gozde Gultekin
    Mesut Toprak
    Hakan Yavuzer
    Murat Emul
    Aging Clinical and Experimental Research, 2017, 29 : 1105 - 1111
12345